COVID-19 Immuno-T™ T cell test grabs the headlines

25 October 2022

Last month ImmunoServ’s latest research in collaboration with Cardiff University was published in the prestigious Nature Communications journal. The research is the culmination of many years research, devotion and hard work. We are especially grateful to all the volunteers who contributed to this work, as well as those who funded the work including UKRI, InnovateUK, and the National Core Studies.


The paper is freely available at the following link.

Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity | Nature Communications

ImmunoServ - Antonio BertolettiThe paper was well received by the research community, creating a lot of scientific debate on Twitter. Moreover, the paper was even selected by Nature’s editors as one of its highlights.

The publication featuring ImmunoServ’s COVID-19 Immuno-TTM T cell test also created a lot of media interest and was featured by several news outlets including The Daily Telegraph, The Western Mail, The Express, Yahoo News and Wales Online.

Pin-prick blood test could avoid need for Covid vaccine – Telegraph

New blood test can tell if you are at risk of Covid – could protect ‘most vulnerable’ – Express

Simple finger-prick blood test can identify people most at risk of being re-infected with Covid – Wales Online

The attention demonstrates the continued interest in immunity to COVID-19 amongst the scientific research community as well as the general public.

If you’re in the UK and interested in performing the T cell test for yourself you can buy it at our consumer website The process is simple: Order your test online; Get your test delivered within 1 week; Post items back in the envelope provided; We’ll email you with your results within 2 weeks. The test enables you to monitor your SARS-CoV-2 specific T cells following vaccination or infection. Thereby empowering you to better understand your risk of getting COVID-19 infection.

If you’re a researcher or clinician interested in using the Immuno-T test in your COVID-19 research or practice please get in touch and we would be delighted to work with you.